United States Infusion Systems Market Outlook to 2023

Publisher Name :
Date: 01-Aug-2017
No. of pages: 113
Price : Single User: US $ 4995  US $ 4246 Corporate User: US $ 14985  US $ 11988
This report is available at 15% Discount for Single User License and 20% Discount for Corporate Users License till 01 September 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

United States Infusion Systems Market Outlook to 2023

Summary

GlobalData's new report, "United States Infusion Systems Market Outlook to 2023", provides key market data on the United States Infusion Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Set, Syringe Pumps and Volumetric Pumps.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Infusion Systems market segments - Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Set, Syringe Pumps and Volumetric Pumps.

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

- 2016 company shares and distribution shares data for each of the market segments.

- Global corporate-level profiles of key companies operating within the United States Infusion Systems market.

- Key players covered include Hospira Inc, Becton Dickinson and Co, Baxter International Inc and Medtronic plc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.\

This report is available at 15% Discount for Single User License and 20% Discount for Corporate Users License till 01 September 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

United States Infusion Systems Market Outlook to 2023

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Infusion Systems Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Infusion Systems Market, United States 9
3.1 Infusion Systems Market, United States, Revenue ($m), 2009-2016 9
3.2 Infusion Systems Market, United States, Revenue ($m), 2016-2023 11
3.2.1 Ambulatory Infusion Pumps Market, United States, Revenue ($m), by Segment, 2009-2016 13
3.2.2 Syringe Pumps Market, United States, Revenue ($m), by Segment, 2009-2016 15
3.2.3 Ambulatory Infusion Pumps Market, United States, Revenue ($m), by Segment, 2016-2023 17
3.2.4 Syringe Pumps Market, United States, Revenue ($m), by Segment, 2016-2023 19
3.3 Infusion Systems Market, United States, Volume (Units), 2009-2016 21
3.4 Infusion Systems Market, United States, Volume (Units), 2016-2023 23
3.4.1 Ambulatory Infusion Pumps Market, United States, Volume (Units), by Segment, 2009-2016 25
3.4.2 Syringe Pumps Market, United States, Volume (Units), by Segment, 2009-2016 27
3.4.3 Ambulatory Infusion Pumps Market, United States, Volume (Units), by Segment, 2016-2023 29
3.4.4 Syringe Pumps Market, United States, Volume (Units), by Segment, 2016-2023 31
3.5 Infusion Systems Market, United States, Average Price ($), 2009-2023 33
3.6 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2015-2016 35
3.7 Infusion Systems Market, United States, Company Share by Revenue ($m), 2016 36
4 Overview of Key Companies in United States, Infusion Systems Market 38
4.1 Hospira Inc 38
4.1.1 Company Overview 38
4.2 Becton Dickinson and Co 38
4.2.1 Company Overview 38
4.3 Baxter International Inc 38
4.3.1 Company Overview 38
4.4 Medtronic Plc 39
4.4.1 Company Overview 39
4.5 Fresenius Kabi AG 39
4.5.1 Company Overview 39
4.6 Smiths Medical 39
4.6.1 Company Overview 39
4.7 B. Braun Melsungen AG 39
4.7.1 Company Overview 39
4.8 Nipro Corp 40
4.8.1 Company Overview 40
5 Infusion Systems Market Pipeline Products 41
6 Financial Deals Landscape 42
6.1 Acquisition 42
6.1.1 Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 42
6.2 Debt Offerings 45
6.2.1 PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 45
6.3 Equity Offerings 46
6.3.1 AngioDynamics Prices Public Offering of Shares for USD38 Million 46
6.3.2 PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 48
6.3.3 PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 49
6.3.4 PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 50
6.3.5 AngioDynamics Prices Public Offering of Shares for USD32 Million 51
6.3.6 PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 53
6.3.7 ConvaTec Raises USD1.8 Billion in IPO 54
6.4 Partnerships 56
6.4.1 Iatric Systems Enters into Agreement with Hospira 56
6.5 Private Equity 57
6.5.1 410 Medical Raises USD3.3 Million in Series A Financing 57
6.6 Venture Financing 58
6.6.1 410 Medical Raises Additional USD2.1 Million in Series A Financing 58
6.6.2 Ivenix Raises USD50 Million in First Tranche of Equity Financing 59
6.6.3 Ivenix Raises USD10 Million in Venture Financing 60
6.6.4 Surefire Medical Raises USD12.8 Million in First Round of Series D Financing 61
7 Recent Developments 62
7.1 Corporate Communications 62
7.1.1 Apr 03, 2017: RMS Strengthens Global Sales Team 62
7.1.2 Mar 30, 2017: IRADIMED Names John McCreery Chief Operating Officer 62
7.1.3 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 62
7.1.4 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 63
7.1.5 Jan 20, 2017: RMS Medical Announces Hiring of Eric Bauer as Chief Operating Officer 64
7.1.6 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 64
7.1.7 Sep 29, 2016: Medipacs Appoints Michael J. Kamdar as Executive Chairman 65
7.1.8 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 65
7.1.9 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 66
7.2 Financial Announcements 66
7.2.1 May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 66
7.2.2 May 08, 2017: Alimera Sciences Reports First Quarter 2017 Financial Results 67
7.2.3 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 68
7.2.4 Apr 28, 2017: Iradimed Announces First Quarter 2017 Financial Results 69
7.2.5 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 69
7.2.6 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 71
7.2.7 Apr 23, 2017: Bard Announces First Quarter Results 72
7.2.8 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 73
7.2.9 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 73
7.2.10 Mar 01, 2017: Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results 74
7.2.11 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 76
7.2.12 Feb 06, 2017: IRADIMED Announces Fourth Quarter 2016 Financial Results 77
7.2.13 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 78
7.2.14 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 80
7.2.15 Jan 26, 2017: Bard Announces Fourth Quarter Results 81
7.2.16 Jan 18, 2017: IRADIMED Announces 2017 Annual and First Quarter Financial Guidance 82
7.2.17 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 82
7.2.18 Dec 27, 2016: RMS Medical Products Posts Third Quarter 2017 Results 83
7.2.19 Nov 02, 2016: Alimera Sciences Announces Third Quarter 2016 Financial Results and Provides Business Update 84
7.2.20 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 86
7.2.21 Oct 28, 2016: IRADIMED Announces Third Quarter 2016 Financial Results 87
7.2.22 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 87
7.2.23 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 88
7.2.24 Oct 25, 2016: Bard Announces Third Quarter Results 90
7.2.25 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 90
7.2.26 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 91
7.2.27 Oct 04, 2016: IRADIMED Revises Financial Guidance for the Third Quarter and Full Year 2016 92
7.2.28 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 93
7.2.29 Aug 03, 2016: Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update 93
7.2.30 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 95
7.2.31 Jul 29, 2016: IRADIMED Announces Second Quarter 2016 Financial Results 96
7.2.32 Jul 26, 2016: Alimera Sciences Pre-Announces Record Second Quarter 2016 Revenue 97
7.2.33 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 97
7.2.34 Jul 26, 2016: Bard Announces Second Quarter Results 98
7.2.35 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 99
7.2.36 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 100
7.2.37 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 101
7.3 Government and Public Interest 103
7.3.1 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 103
7.4 Legal And Regulatory 104
7.4.1 May 22, 2017: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome-Data Presented at Antiepileptic Drug Trials XIV 2017 Conference 104
7.4.2 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 105
7.4.3 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 106
7.5 Other Significant Developments 106
7.5.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 106
7.5.2 Nov 30, 2016: Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software 107
7.5.3 Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner 107
7.6 Product News 108
7.6.1 Mar 20, 2017: Surefire Receives Regulatory Approval for Infusion Systems and Guiding Catheters in Mexico 108
8 Appendix 109
8.1 Research Methodology 110
8.1.1 Coverage 110
8.1.2 Secondary Research 110
8.1.3 Primary Research 111
8.1.4 Company Share Analysis 111
8.1.5 Distribution Share Analysis 111
8.1.6 Benchmarking 112
8.2 GlobalData Consulting 112
8.3 Contact Us 113
8.4 Disclaimer 113

1.1 List of Tables
Table 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 10
Table 2: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 12
Table 3: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
Table 4: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
Table 5: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Table 6: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Table 7: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016 22
Table 8: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023 24
Table 9: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016 26
Table 10: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016 28
Table 11: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023 30
Table 12: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023 32
Table 13: Infusion Systems Market, United States, Average Price ($), Historic, 2009-2016 33
Table 14: Infusion Systems Market, United States, Average Price ($), Forecast, 2016-2023 34
Table 15: Infusion Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 35
Table 16: Infusion Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2016 37
Table 17: Infusion Systems Market Pipeline Products 41
Table 18: Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 42
Table 19: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 45
Table 20: AngioDynamics Prices Public Offering of Shares for USD38 Million 46
Table 21: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 48
Table 22: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 49
Table 23: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 50
Table 24: AngioDynamics Prices Public Offering of Shares for USD32 Million 51
Table 25: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 53
Table 26: ConvaTec Raises USD1.8 Billion in IPO 54
Table 27: Iatric Systems Enters into Agreement with Hospira 56
Table 28: 410 Medical Raises USD3.3 Million in Series A Financing 57
Table 29: 410 Medical Raises Additional USD2.1 Million in Series A Financing 58
Table 30: Ivenix Raises USD50 Million in First Tranche of Equity Financing 59
Table 31: Ivenix Raises USD10 Million in Venture Financing 60
Table 32: Surefire Medical Raises USD12.8 Million in First Round of Series D Financing 61

1.2 List of Figures
Figure 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
Figure 2: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
Figure 3: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
Figure 4: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
Figure 5: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 17
Figure 6: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 7: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016 21
Figure 8: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023 23
Figure 9: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016 25
Figure 10: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016 27
Figure 11: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023 29
Figure 12: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023 31
Figure 13: Infusion Systems Market, United States, Company Share (%) 2016 36
  • Global Drug Delivery Devices Market Research Report 2017
    Published: 16-Aug-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Drug Delivery Devices in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • United States Metered Dose Inhaler Devices Market Report 2017
    Published: 16-Aug-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Metered Dose Inhaler Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market shar......
  • United States Drug Delivery Devices Market Report 2017
    Published: 15-Aug-2017        Price: US 3800 Onwards        Pages: 116
    In this report, the United States Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Dr......
  • Global Autoinjectors Market Professional Survey Report 2017
    Published: 15-Aug-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Autoinjectors in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AntAntares Pharma, Inc. - Biogen Idec, Inc. - Becton - Dickinson and C......
  • Global Drug Delivery Devices Sales Market Report 2017
    Published: 10-Aug-2017        Price: US 4000 Onwards        Pages: 121
    In this report, the global Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drug Delivery Devices for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe ......
  • North America Metered Dose Inhaler Devices Market Outlook to 2023
    Published: 01-Aug-2017        Price: US 5995 Onwards        Pages: 64
    North America Metered Dose Inhaler Devices Market Outlook to 2023 Summary GlobalData's new report, "North America Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the North America Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices. The report also provides company shares and distribution shares data for ea......
  • EU5 Metered Dose Inhaler Devices Market Outlook to 2023
    Published: 01-Aug-2017        Price: US 5995 Onwards        Pages: 114
    EU5 Metered Dose Inhaler Devices Market Outlook to 2023 Summary GlobalData's new report, "EU5 Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the EU5 Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices. The report also provides company shares and distribution shares data for each of these market segments, a......
  • Asia-Pacific Metered Dose Inhaler Devices Market Outlook to 2023
    Published: 01-Aug-2017        Price: US 5995 Onwards        Pages: 65
    Asia-Pacific Metered Dose Inhaler Devices Market Outlook to 2023 Summary GlobalData's new report, "Asia-Pacific Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the Asia-Pacific Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices. The report also provides company shares and distribution shares data for each ......
  • BRIC Metered Dose Inhaler Devices Market Outlook to 2023
    Published: 01-Aug-2017        Price: US 5995 Onwards        Pages: 55
    BRIC Metered Dose Inhaler Devices Market Outlook to 2023 Summary GlobalData's new report, "BRIC Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the BRIC Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices. The report also provides company shares and distribution shares data for each of these market segments......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs